Medical Microinstruments, Inc. (MMI) has reached a landmark in robotic-assisted microsurgery with the first clinical use of its new NanoWrist™ dissection instruments and Synaptix™ Digital Surgery Platform, performed at The Royal Marsden NHS Foundation Trust in London. This milestone represents the first time precision tissue dissection and a fully integrated digital workflow have been deployed in open microsurgery using the Symani® Surgical System. The NanoWrist scissors and forceps are the world’s first fully wristed robotic instruments designed specifically for soft tissue dissection, allowing for gentle, accurate manipulation of delicate structures such as vessels and tissues during complex procedures.

These technologies are purpose-built to enhance surgical control, reduce trauma, and support improved patient outcomes in areas like breast reconstruction, head and neck surgery, and lymphedema repair. The Synaptix Digital Surgery Platform complements this innovation by delivering real-time visual enhancements and workflow streamlining, empowering the entire surgical team. As the first digital platform specifically developed for open microsurgery, Synaptix aims to reduce variability, increase consistency, and provide meaningful surgical intelligence throughout the operative process.

Together, these advancements mark a significant expansion of MMI’s robotic microsurgery capabilities beyond vascular anastomosis, offering surgeons a more comprehensive and precise toolset. By addressing long-standing limitations in microsurgical access and control, MMI continues to redefine what is possible in delicate surgical interventions. This early clinical deployment in Europe is a strategic step toward broader global adoption, reinforcing MMI’s mission to improve quality of life for patients through innovative and transformative microsurgical technology.